Free Trial

Insider Selling: Teladoc Health, Inc. (NYSE:TDOC) Insider Sells 2,358 Shares of Stock

Teladoc Health logo with Medical background

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) insider Fernando M. Rodrigues sold 2,358 shares of the business's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $16,175.88. Following the sale, the insider now owns 4,174 shares of the company's stock, valued at approximately $28,633.64. This represents a 36.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Fernando M. Rodrigues also recently made the following trade(s):

  • On Tuesday, June 3rd, Fernando M. Rodrigues sold 4,174 shares of Teladoc Health stock. The stock was sold at an average price of $6.91, for a total value of $28,842.34.

Teladoc Health Price Performance

NYSE:TDOC traded up $0.35 during trading hours on Friday, reaching $7.28. 5,275,426 shares of the company traded hands, compared to its average volume of 6,288,824. The firm's 50-day moving average is $7.15 and its 200-day moving average is $9.13. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The stock has a market cap of $1.28 billion, a P/E ratio of -1.26 and a beta of 1.82. Teladoc Health, Inc. has a 1-year low of $6.35 and a 1-year high of $15.21.

Wall Street Analysts Forecast Growth

TDOC has been the topic of several analyst reports. The Goldman Sachs Group reduced their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Truist Financial lowered their target price on Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a report on Tuesday, May 27th. Jefferies Financial Group cut their price target on Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a research note on Monday, April 21st. Canaccord Genuity Group reduced their price target on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Finally, Evercore ISI lowered their target price on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating for the company in a report on Thursday, May 1st. Twelve analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $9.60.

View Our Latest Analysis on Teladoc Health

Institutional Investors Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Golden State Wealth Management LLC boosted its holdings in shares of Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after buying an additional 1,690 shares during the period. National Bank of Canada FI lifted its stake in Teladoc Health by 79.4% during the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock valued at $28,000 after purchasing an additional 1,581 shares during the last quarter. Whipplewood Advisors LLC purchased a new stake in shares of Teladoc Health in the 4th quarter valued at approximately $29,000. Lindbrook Capital LLC increased its stake in Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after buying an additional 1,612 shares during the period. Finally, SVB Wealth LLC acquired a new position in Teladoc Health in the 1st quarter valued at approximately $37,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Recommended Stories

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Should You Invest $1,000 in Teladoc Health Right Now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double
The Next Palantir? AI-Defense Stock Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines